Trial Details
COMPLETEDBasic Information
| Clinical ID | c4054 |
|---|---|
| Identifier | NCT01114607 |
| Trial Title | A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: GSK1605786 ChemoCentryx: formulation A|DRUG: GSK1605786 GSK: formulation B|DRUG: GSK1605786 GSK direct-fill: formulation C|DRUG: GSK1605786 GSK modified-process: formulation D|DRUG: GSK1605786 GSK tablet: formulation E |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Buffalo |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2010-05-05 |
|---|---|
| Primary Completion Date | 2010-06-29 |
| Completion Date | 2010-06-29 |